1. Home
  2. RFL vs HGBL Comparison

RFL vs HGBL Comparison

Compare RFL & HGBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RFL
  • HGBL
  • Stock Information
  • Founded
  • RFL 2017
  • HGBL 1937
  • Country
  • RFL United States
  • HGBL United States
  • Employees
  • RFL N/A
  • HGBL N/A
  • Industry
  • RFL Real Estate
  • HGBL Business Services
  • Sector
  • RFL Finance
  • HGBL Consumer Discretionary
  • Exchange
  • RFL Nasdaq
  • HGBL Nasdaq
  • Market Cap
  • RFL 54.4M
  • HGBL 51.1M
  • IPO Year
  • RFL N/A
  • HGBL N/A
  • Fundamental
  • Price
  • RFL $1.34
  • HGBL $1.48
  • Analyst Decision
  • RFL
  • HGBL Strong Buy
  • Analyst Count
  • RFL 0
  • HGBL 1
  • Target Price
  • RFL N/A
  • HGBL $4.00
  • AVG Volume (30 Days)
  • RFL 75.0K
  • HGBL 86.3K
  • Earning Date
  • RFL 12-10-2025
  • HGBL 11-06-2025
  • Dividend Yield
  • RFL N/A
  • HGBL N/A
  • EPS Growth
  • RFL N/A
  • HGBL N/A
  • EPS
  • RFL N/A
  • HGBL 0.10
  • Revenue
  • RFL $917,000.00
  • HGBL $48,940,000.00
  • Revenue This Year
  • RFL N/A
  • HGBL $20.86
  • Revenue Next Year
  • RFL N/A
  • HGBL $4.61
  • P/E Ratio
  • RFL N/A
  • HGBL $14.66
  • Revenue Growth
  • RFL 43.96
  • HGBL N/A
  • 52 Week Low
  • RFL $1.28
  • HGBL $1.39
  • 52 Week High
  • RFL $3.19
  • HGBL $2.39
  • Technical
  • Relative Strength Index (RSI)
  • RFL 44.34
  • HGBL 39.75
  • Support Level
  • RFL $1.30
  • HGBL $1.40
  • Resistance Level
  • RFL $1.37
  • HGBL $1.49
  • Average True Range (ATR)
  • RFL 0.05
  • HGBL 0.06
  • MACD
  • RFL 0.00
  • HGBL 0.01
  • Stochastic Oscillator
  • RFL 22.50
  • HGBL 44.74

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.

About HGBL Heritage Global Inc.

Heritage Global Inc values and monetizes industrial and financial assets by providing acquisition, disposition, valuation, and lending services for surplus and distressed assets. It aids in facilitating the economy by diverting useful industrial assets from landfills and operating a supply chain by overseeing the post-sale account activity of financial assets. The group operates in four segments namely Auction and Liquidation; Refurbishment and Resale; Brokerage and Specialty Lending. It generates maximum revenue from the Auction and Liquidation segment. The Auction and Liquidation segment, through HGP, operates as a full-service auction, appraisal, and asset advisory firm, including the acquisition of turnkey manufacturing facilities and used industrial machinery and equipment.

Share on Social Networks: